A hydrogel built from the antimicrobial peptide ε-poly-lysine, combined with light-triggered nitric oxide release, successfully eliminated drug-resistant bacterial and fungal biofilms and accelerated healing of infected diabetic wounds in mice.
3-Stage NO ReleaseThe peptide hydrogel slowly disperses biofilms, then rapidly kills resistant pathogens with laser activation, then sustains tissue repair — all from a single dressing
What the researchers found
The DEPN hydrogel demonstrated a three-stage nitric oxide release strategy: continuous slow release to disperse biofilms, laser-triggered rapid burst release (with photothermal heating) to eliminate pathogens, and sustained slow release to promote tissue remodeling. The hydrogel effectively eliminated a broad spectrum of drug-resistant Gram-positive bacteria, Gram-negative bacteria, and fungal biofilms through synergistic effects of NO, photothermal therapy, and the antimicrobial peptide ε-poly-lysine.
In vitro, the hydrogel promoted proliferation of mouse fibroblasts and migration of endothelial cells. In vivo, it achieved exceptional therapeutic outcomes in mice with MRSA-infected diabetic wounds by eliminating biofilm infection, regulating inflammation, facilitating angiogenesis, and promoting collagen deposition — addressing the multiple barriers that prevent chronic wound healing.
Why it matters
Chronic wounds affect millions worldwide, with diabetic foot ulcers alone costing healthcare systems billions annually. Drug-resistant biofilm infections make these wounds extremely difficult to treat with conventional antibiotics. This peptide-based hydrogel addresses multiple wound healing barriers simultaneously — killing resistant bacteria, breaking up protective biofilms, controlling inflammation, and promoting tissue repair — offering a potential solution for wounds that currently have few effective treatments.
How the study worked
The hydrogel was constructed via Schiff-base crosslinking of oxidized dextran with the antimicrobial peptide ε-poly-lysine, with encapsulated photothermal nanoparticles carrying a nitric oxide donor. In vitro testing assessed biofilm dispersal, fibroblast proliferation, and endothelial cell migration. Antimicrobial activity was tested against drug-resistant Gram-positive/negative bacteria and fungi. In vivo efficacy was evaluated in a diabetic mouse wound model infected with methicillin-resistant Staphylococcus aureus (MRSA), with assessment of infection clearance, inflammation, angiogenesis, and collagen deposition.
What this study cannot tell us
All experiments were conducted in mice, and wound healing in mice differs significantly from humans in skin structure and immune response. The diabetic wound model was artificially induced and may not fully replicate the complexity of human diabetic wounds. Long-term safety of the photothermal nanoparticles was not assessed. The need for NIR laser equipment adds complexity and cost that could limit clinical adoption. Specific quantitative data on wound closure rates were not provided in the abstract.
How to read the evidence
This is a preclinical study with both in vitro and in vivo (mouse) experiments. While it demonstrates promising proof-of-concept results including MRSA biofilm clearance in a diabetic wound model, no human testing has been performed. This is early-stage evidence that would need extensive clinical translation.
When this study was published
Published in 2024, this is very recent work at the forefront of antimicrobial peptide-based wound care materials, reflecting current efforts to address the growing crisis of antibiotic-resistant wound infections.
The bigger picture
Antimicrobial peptides are increasingly recognized as alternatives to conventional antibiotics, especially against drug-resistant infections. This study demonstrates how peptides can serve dual roles — as both structural scaffold components and active antimicrobial agents — in advanced wound care materials. The integration of peptides with stimuli-responsive drug delivery (light-triggered NO release) represents a convergence of peptide science, nanotechnology, and regenerative medicine.
Questions still open
- How would this hydrogel perform in larger animal models or human chronic wound trials?
- Could the ε-poly-lysine peptide component alone provide sufficient antimicrobial activity without the photothermal system for simpler clinical applications?
- What is the long-term fate of the photothermal nanoparticles in wound tissue — are they safely cleared from the body?
Common questions
What is ε-poly-lysine and why is it used in this wound dressing?
How does light help this wound dressing fight infection?
Read the original research
A photo-modulated nitric oxide delivering hydrogel for the accelerated healing of biofilm infected chronic wounds.
Acta biomaterialia, 188, 169-183
Citation
Ma, Huifang; Wang, Tengjiao; Li, Gangfeng; Liang, Jiaheng; Zhang, Jianhong; Liu, Yang; Zhong, Wenbin; Li, Peng. (2024). A photo-modulated nitric oxide delivering hydrogel for the accelerated healing of biofilm infected chronic wounds.. Acta biomaterialia, 188, 169-183. https://doi.org/10.1016/j.actbio.2024.09.017